About Summit Therapeutics
Summit Therapeutics Inc. is a biopharmaceutical oncology company committed to the discovery, development, and commercialization of patient-, physician-, caregiver-, and societal-friendly medicinal therapies. The company's mission focuses on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs, particularly in the field of oncology.
Headquartered in Miami, Florida, with additional offices in Palo Alto, California; Princeton, New Jersey; Oxford, UK; and Dublin, Ireland, Summit Therapeutics has positioned itself as a leader in cancer treatment innovation. The company's lead pipeline candidate is ivonescimab, a novel bispecific antibody targeting both PD-1 and VEGF. In January 2023, Summit established a collaboration and license agreement with Akeso, Inc. for ivonescimab, gaining rights to develop and commercialize the therapy in the United States, Canada, Europe, Japan, Latin America, the Middle East, and Africa.
Summit is currently conducting multiple global Phase 3 clinical trials for ivonescimab, including studies in non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). The company has initiated several Phase 3 trials including HARMONi, HARMONi-3, HARMONi-7, and HARMONi-GI3, demonstrating a commitment to advancing oncology treatment options. With a leadership team that has a proven track record in drug development, regulatory approval, and commercialization, Summit is positioning itself for durable growth while maintaining its focus on patient-centered innovation.
FAQs
- When was Summit Therapeutics founded?
- Summit Therapeutics was founded in 2003.
- Who is the CEO of Summit Therapeutics?
- Robert Duggan; Maky Zanganeh is the CEO.
- What industries or markets does Summit Therapeutics operate in?
- Summit Therapeutics operates in the following markets: Biopharmaceutical, Cancer Therapeutics, Biologics & Monoclonal Antibodies, Bispecific Antibody Therapeutics, Clinical Stage Drug Development, Clinical Trials (Phase 3), Pharmaceutical Commercialization, Biotech Licensing & Strategic Partnerships, Oncology, and Immuno Oncology.
- How many employees does Summit Therapeutics have?
- Summit Therapeutics has 201-500 employees.
- Where does Summit Therapeutics have employees?
- Summit Therapeutics has employees in United States.
- Is Summit Therapeutics hiring?
- Yes, Summit Therapeutics has 6 open remote jobs.
- Does Summit Therapeutics support remote work or working from home?
- Yes, Summit Therapeutics is a remote-friendly company.
- What employee benefits does Summit Therapeutics offer?
- Summit Therapeutics provides 5 benefits to their employees.
- Does Summit Therapeutics offer a four-day work week?
- No, Summit Therapeutics does not offer a four-day work week.
- Is Summit Therapeutics transparent about salaries?
- Yes, Summit Therapeutics practices salary transparency, often including salary or compensation ranges in their job posts. They provide salary data for 10 roles.
- What is Summit Therapeutics's tech stack?
- Summit Therapeutics has 2 technologies in their tech stack.
- What is Summit Therapeutics's website?
- Summit Therapeutics's website is smmttx.com.
United States
United Kingdom only
AU, CA + 7 more